Literature DB >> 13975014

Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine.

E C ROSENZWEIG, R W BABIONE, C L WISSEMAN.   

Abstract

Entities:  

Keywords:  HEMAGGLUTINATION INHIBITION TESTS; NEUTRALIZATION TESTS; VACCINES; YELLOW FEVER VIRUS

Mesh：

Substances：

Year:  1963        PMID： 13975014

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  9 in total

1.  Yellow fever vaccine seroconversion in travelers.

Authors:  Allison Kay; Lin H Chen; Maggie Sisti; Thomas P Monath
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

Review 2.  Advances and controversies in yellow fever vaccination.

Authors:  Emile F F Jonker; Leonardus G Visser; Anna H Roukens
Journal:  Ther Adv Vaccines       Date:  2013-11

Review 3.  Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection.

Authors:  J Erin Staples; Alan D T Barrett; Annelies Wilder-Smith; Joachim Hombach
Journal:  NPJ Vaccines       Date:  2020-07-06       Impact factor: 7.344

4.  Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.

Authors:  J D Poland; C H Calisher; T P Monath; W G Downs; K Murphy
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

Review 5.  Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

Authors:  Eduardo Gotuzzo; Sergio Yactayo; Erika Córdova
Journal:  Am J Trop Med Hyg       Date:  2013-09       Impact factor: 2.345

6.  Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers.

Authors:  Nicole P Lindsey; Kalanthe A Horiuchi; Corey Fulton; Amanda J Panella; Olga I Kosoy; Jason O Velez; Elizabeth R Krow-Lucal; Marc Fischer; J Erin Staples
Journal:  J Travel Med       Date:  2018-01-01       Impact factor: 8.490

Review 7.  Questions regarding the safety and duration of immunity following live yellow fever vaccination.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2016-06-20       Impact factor: 5.683

Review 8.  Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection.

Authors:  J Erin Staples; Alan D T Barrett; Annelies Wilder-Smith; Joachim Hombach
Journal:  NPJ Vaccines       Date:  2020-07-06       Impact factor: 7.344

Review 9.  Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects.

Authors:  Elena Gianchecchi; Virginia Cianchi; Alessandro Torelli; Emanuele Montomoli
Journal:  Vaccines (Basel)       Date:  2022-02-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.